[go: up one dir, main page]

EE200300140A - Propanoic acid derivatives with PPAR alpha-activating properties - Google Patents

Propanoic acid derivatives with PPAR alpha-activating properties

Info

Publication number
EE200300140A
EE200300140A EEP200300140A EEP200300140A EE200300140A EE 200300140 A EE200300140 A EE 200300140A EE P200300140 A EEP200300140 A EE P200300140A EE P200300140 A EEP200300140 A EE P200300140A EE 200300140 A EE200300140 A EE 200300140A
Authority
EE
Estonia
Prior art keywords
acid derivatives
propanoic acid
ppar alpha
activating properties
activating
Prior art date
Application number
EEP200300140A
Other languages
Estonian (et)
Inventor
Urbahns Klaus
Woltering Michael
Nikolic Susanne
Pernerstorfer Josef
Hinzen Berthold
Dittrich-Wengenroth Elke
Bischoff Hilmar
Hirth-Dietrich Claudia
Lustig Klemens
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10124905A external-priority patent/DE10124905A1/en
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of EE200300140A publication Critical patent/EE200300140A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EEP200300140A 2000-10-05 2001-09-24 Propanoic acid derivatives with PPAR alpha-activating properties EE200300140A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10049208 2000-10-05
DE10124905A DE10124905A1 (en) 2000-10-05 2001-05-22 propionic acid derivatives
PCT/EP2001/011005 WO2002028821A2 (en) 2000-10-05 2001-09-24 Propionic acid derivatives with ppar-alpha activating properties

Publications (1)

Publication Number Publication Date
EE200300140A true EE200300140A (en) 2003-08-15

Family

ID=26007267

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300140A EE200300140A (en) 2000-10-05 2001-09-24 Propanoic acid derivatives with PPAR alpha-activating properties

Country Status (22)

Country Link
EP (1) EP1328508A2 (en)
JP (1) JP2004510757A (en)
CN (1) CN1479716A (en)
AU (1) AU2001293838A1 (en)
BG (1) BG107684A (en)
BR (1) BR0114437A (en)
CA (1) CA2424540A1 (en)
CZ (1) CZ2003964A3 (en)
EE (1) EE200300140A (en)
HN (1) HN2001000223A (en)
HR (1) HRP20030346A2 (en)
HU (1) HUP0302306A3 (en)
IL (1) IL155125A0 (en)
MA (1) MA25917A1 (en)
MX (1) MXPA03002901A (en)
NO (1) NO20031517L (en)
NZ (1) NZ525119A (en)
PL (1) PL361162A1 (en)
RU (1) RU2003112968A (en)
SK (1) SK4132003A3 (en)
UY (1) UY26951A1 (en)
WO (1) WO2002028821A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10151390A1 (en) * 2001-10-18 2003-05-08 Bayer Ag acetic acid derivatives
GB0214254D0 (en) * 2002-06-20 2002-07-31 Glaxo Group Ltd Chemical compounds
HRP20050336B1 (en) * 2002-10-21 2013-06-30 Janssen Pharmaceutica N.V. SUBSTITUTED TETRALINS AND INDANES AND THEIR APPLICATIONS
WO2004037778A1 (en) * 2002-10-21 2004-05-06 Janssen Pharmaceutica, N.V. Substituted tetralins and indanes
US20040171680A1 (en) * 2002-10-21 2004-09-02 Xiiaoli Chen Treating Syndrome X with substituted tetralins and indanes
EP1583754A1 (en) * 2003-01-06 2005-10-12 Eli Lilly And Company Thiophene derivative ppar modulators
KR101186386B1 (en) 2003-08-29 2012-09-26 오노 야꾸힝 고교 가부시키가이샤 Compound capable of binding s1p receptor and pharmaceutical use thereof
AR048931A1 (en) 2004-04-21 2006-06-14 Janssen Pharmaceutica Nv PROCESS FOR THE PREPARATION OF SUBSTITUTED AND INDIAN TETRALIN DERIVATIVES AND PREPARATION OF SYNTHESIS INTERMEDIARIES
CN100344618C (en) 2004-05-24 2007-10-24 北京摩力克科技有限公司 N-benzyl acryloyl substituted tyrosine derivatives as hPPAR alpha and hPPAR gamma agonist
KR100699928B1 (en) 2004-10-05 2007-03-26 재단법인서울대학교산학협력재단 Method for preparing intermediates for the preparation of peroxysomal proliferator activated receptor alpha ligands
EP2371811B1 (en) 2004-12-13 2014-10-08 Ono Pharmaceutical Co., Ltd. Azetidinecarboxylic acid derivative and medicinal use thereof
CN101054372B (en) * 2006-04-11 2010-10-13 中国科学院上海药物研究所 Pyrimidine substituted benzenepropanoic acid derivative, its preparation method and use in curing polycystic kidney disease
EP2380884B1 (en) 2008-12-01 2014-02-12 Mitsubishi Tanabe Pharma Corporation Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof
JP5436941B2 (en) * 2009-06-03 2014-03-05 あすか製薬株式会社 Lactam compound or salt thereof and PPAR activator
UY34200A (en) 2011-07-21 2013-02-28 Bayer Ip Gmbh 3- (FLUOROVINIL) PIRAZOLES AND ITS USE
CN107406484A (en) * 2014-12-11 2017-11-28 中化帝斯曼制药有限公司荷兰公司 The method of acylated cyclic peptide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2320387A1 (en) * 1973-04-21 1974-10-31 Boehringer Mannheim Gmbh PHENOXYALKYLCARBONIC ACID DERIVATIVES AND METHOD FOR PREPARING THE SAME
GB9822473D0 (en) * 1998-10-16 1998-12-09 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
MA25917A1 (en) 2003-10-01
CZ2003964A3 (en) 2003-08-13
HN2001000223A (en) 2001-10-25
CA2424540A1 (en) 2003-04-02
PL361162A1 (en) 2004-09-20
NO20031517D0 (en) 2003-04-03
RU2003112968A (en) 2004-09-20
NZ525119A (en) 2005-04-29
AU2001293838A1 (en) 2002-04-15
BR0114437A (en) 2003-07-01
CN1479716A (en) 2004-03-03
SK4132003A3 (en) 2004-02-03
NO20031517L (en) 2003-05-28
BG107684A (en) 2003-10-31
WO2002028821A2 (en) 2002-04-11
HRP20030346A2 (en) 2005-04-30
HUP0302306A2 (en) 2003-10-28
HUP0302306A3 (en) 2005-02-28
UY26951A1 (en) 2002-06-20
IL155125A0 (en) 2003-10-31
EP1328508A2 (en) 2003-07-23
MXPA03002901A (en) 2003-10-15
JP2004510757A (en) 2004-04-08
WO2002028821A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
DE50212761D1 (en) NOVEL AMINODIC ACETIC ACID DERIVATIVES
EE200300274A (en) Sulfonamidoether substituted imidazoquinolines
NO20031097L (en) quinoline
NO20025978L (en) Benzothiazole derivatives
EE200300140A (en) Propanoic acid derivatives with PPAR alpha-activating properties
DE50104794D1 (en) SUBSTITUTED ANTHRANILIC ACIDS
EE200400023A (en) New sulphonic acid derivatives
DE50005284D1 (en) SUBSTITUTED N-BENZYL-INDOL-3-YL-GLYOXYLIC ACID DERIVATIVES WITH ANTITUARY EFFECT
DE10196948T1 (en) Environmental monitoring methods
ATE414056T1 (en) SUBSTITUTED C-CYCLOHEXYLMETHYLAMINE DERIVATIVES
ATE309220T1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDROCINOLINE-2-CARBOXYLIC ACID DERIVATIVES
NO20025542D0 (en) quinolonecarboxylic acid derivatives
ATE282021T1 (en) SUBSTITUTED AMINOMETHYL-PHENYL-CYCLOHEXANE DERIVATIVES
ATE272045T1 (en) SUBSTITUTED 1-AMINOBUTANE-3-OL DERIVATIVES
EP1267898A4 (en) GALLENIC ACID CONTAINING PROPHARMAKA WITH INCREASED BIOAVIBILITY
ATE361274T1 (en) SUBSTITUTED 5-AMINO-1-PENTENE-3-OL DERIVATIVES
NO20042664L (en) carboxylic acid
AR028237A1 (en) ACETILSALICILIC ACID SOLUTIONS
IS8301A (en) New Fusic Acid Derivatives
SE0000973D0 (en) Triangle buck
UA4756S (en) SMALL TRAWLER
DK1246793T3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives